Interview with André Choulika, President, France Biotech
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
Boston Scientific is a leading innovator of medical solutions seeking to improve the health of patients around the world. The company’s products and technologies are used to diagnose and treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women’s health, and chronic pain conditions. With the company’s European headquarters based in France, Boston Scientific’s presence in Europe is dedicated to state of the art innovations reciprocated by high performance in the region. Also within France is the Institute for Advancing Science (IAS), serving as a professional education platform, representing the company’s commitment to education and intensive industry training. Working with integrity and compassion to best support patient’s well-being, Boston Scientific strives to achieve meaningful innovation and high performance in all of its areas of expertise. Leading with the company slogan, “Advancing science for life™,” the company is determined to change and act with speed, agility and accountability to further improve patient care.
Contact
Address: 2 Rue René Caudron, 78960 Voisins-le-Bretonneux, France
Phone:+33 1 39 30 49 00
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
